MADINA SAIPOVA: Open Payments
NPI 1558069922 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 32 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $147 |
| PFIZER INC. | 7 | $143 |
| Lilly USA, LLC | 4 | $72 |
| Astellas Pharma US Inc | 2 | $52 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Boston Scientific Corporation | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
Products named: Wegovy, NURTEC ODT, Veozah, Auvelity, ZEPBOUND, General - Pain Management, Rybelsus, Kerendia.
Industry payments across GA — which companies pay providers there.
